Chamber to Share Region’s Life Sciences Story at BIO 2023

It was four years ago, at the 2019 BIO International Convention held in Philadelphia, that the Chamber of Commerce for Greater Philadelphia launched the region’s Cell & Gene Therapy and Connected Health Initiative to further boost the market as a leading center for life sciences and a top cell and gene therapy, gene editing, and connected health technology hub. The global attendees at the convention, representing biotech leaders from more than 30 countries, were the ideal audience to hear the news of the region’s expertise and expansion efforts in these industries.

Since 2019, the region’s rapidly expanding life sciences industry has […]

Women Lead Life Sciences Job Growth in Region

As the number of life sciences jobs in the Greater Philadelphia region grows, an increasing number of those jobs are being held by women, according to data the Chamber of Commerce for Greater Philadelphia analyzed from Lightcast, a global labor market data and analytics company. Over the past decade, Philadelphia has seen a 12% increase in women working in life sciences occupations compared  to 8.6% growth for men (Lightcast’s Historical Demographics by Occupation, 2023), including growth in cell and gene therapy roles. The uptick is reflected across professions, including biochemists and biophysicists, medical scientists, biological scientists, and biological technicians.

Lightcast also […]

Penn Center for Innovation Report Highlights Record-Breaking Commercialization Activity

In the center of Philadelphia, on the campus of the University of Pennsylvania, sits an institution that enhances Greater Philadelphia’s growing reputation for scientific and technological innovation. At the Penn Center for Innovation (PCI), Penn’s inventors are connected with the resources they need to translate discoveries into products and businesses that can have a societal impact. Penn faculty members and researchers, companies seeking strategic alliances, entrepreneurs, and many other types of Penn innovators – PCI serves them all, as it works to bring promising technologies and start-up ideas to light. In its recent PCI […]

ChristianaCare Spins Out CorriXR Therapeutics

On October 11, 2022, Wilmington, Delaware-based ChristianaCare announced it had spun out its first commercial biotechnology private startup company, CorriXR Therapeutics. The startup will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung.

CorriXR Therapeutics’ close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions the new company to research and develop innovative, patient-centered therapies, the nonprofit health system said in its release. CorriXR Therapeutics will license technology from the Gene Editing Institute and work closely with its […]

Life Sciences PA Shares Industry Impact Report

Our region’s life sciences ecosystem has three new assets we can all use to amplify the discovery, talent, and momentum in Greater Philadelphia. The first is a study by Econsult ranking Greater Philadelphia #2 in cell and gene therapy compared with 14 U.S. cell and gene therapy clusters. You can read about the research and link to the report here; it was recently featured in the trade publication Cell & Gene. The second is JLL’s  2022 Life Sciences Research Outlook & Cluster Rankings, in […]

Comparative Study Ranks Philadelphia Region #2 Among 14 Cell and Gene Therapy Hubs

In a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories, the Philadelphia region ranks #2 among U.S. locations. Commissioned by the Chamber of Commerce for Greater Philadelphia and researched by economic consulting firm Econsult Solutions, Inc. (ESI), the study compares cell and gene therapy hubs in research infrastructure, human capital, innovation output, commercial activity, and value proposition. The only region ranked higher overall than Philadelphia was Boston. New York and San Francisco were ranked #3 and #4, respectively.

“The Philadelphia region is increasingly attracting new […]

Five Organizations Partner to Design New Biotech Training Program to Connect Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Sciences Sector

The Wistar Institute, West Philadelphia Skills Initiative, Iovance Biotherapeutics, PIDC, and The Chamber of Commerce for Greater Philadelphia Launch Recruitment for the Pilot Program.

Partners in Greater Philadelphia’s life sciences ecosystem are collaborating to create a new workforce development training model to connect biotech jobs with a wider range of Philadelphians, including residents from disadvantaged communities. In a field that often requires PhDs or master’s degrees for most roles, the program – “Biomedical Technician Training Program: Aseptic Manufacturing” – will create opportunities for Philadelphians with at least a high school equivalency. The initiative is one way the region is working together […]

Philadelphia Region’s Ever-Expanding Cell and Gene Therapy Family Tree Featured in New Promotional Reel

An initiative launched more than three years ago to boost awareness of the region as a hub for cell and gene therapy is getting ready to unveil its latest effort to promote the fast-growing sector.

Called “Greater Philadelphia: Discovery Starts Here,” the 90-second graphic animation illustrates how more than a dozen companies have spun out of, or are licensing technology from, a handful of local research institutions. It is also available for download here.

Specifically, the video animation features five research institutions (The University of Pennsylvania, Children’s Hospital of Philadelphia, Jefferson Health, Temple University, and The Wistar […]

AmerisourceBergen Establishes Cell and Gene Therapy Service Line

AmerisourceBergen, a global healthcare services company headquartered in Greater Philadelphia, announced it has formally established a cell and gene therapy service line as part of its commitment to support cell and gene therapy innovators. This new service line will be led by Lung-I Cheng, Ph.D., who recently joined AmerisourceBergen as Vice President of Cell and Gene Therapy. 

Cheng will work to evolve and enhance the end-to-end support AmerisourceBergen provides cell and gene therapy innovators throughout the commercialization journey. As part of that effort, Cheng noted AmerisourceBergen […]

Go to Top